Dr. James M. Bienvenu, MD

Husband. Father. Amateur Chef. Bad Golfer.

James M Bienvenu MD

“I strive to provide evidence-based, technologically advanced, and empathetic care for all patients with urologic cancers.”

— James M Bienvenu MD

About Me

Gender: Male

Languages Spoken:
English

Locations:

UT Medical Center (B-222)

Northshore Town Center

Sweetwater Hospital

Clinical Focus:

Bladder Cancer, Prostate Cancer, Adrenal Cancer, Kidney Cancer, Penile Cancer, Testicular Cancer, General Urology, Minimally Invasive Surgery, Urologic Oncology, DaVinci Surgery, Robotic Surgery, Transperineal Prostate Biopsy, Barrigel, SpaceOAR, High Intensity Focused Ultrasound for Prostate Cancer, HIFU, Focal Therapy, MRI Guided Prostate Biospy

About James M Bienvenu MD:

My clinical practice focuses heavily on Urologic cancers. Taking care of and helping those who are sometimes in their most difficult journeys, is very rewarding. I was born and raised in south Louisiana. I am a third generation physician, who was fortunate enough to witness my father and grandfathers care for their patients with empathy and respect. Watching my younger brother battle cancer has been the most impactful life experience as it relates to my personal interactions with my own patients.

I focus on offering patients with urologic malignancies the most technologically advanced care. I strive to make sure we attain the highest levels of cancer control possible without sacrificing quality of life.

When I am not at work, I enjoy spending time with my wife and children. Outdoor activities, cooking, and watching sports are my favorite past-times.

Cancer surgery is more about just curing cancer…

Dr. Bienvenu believes organ sparing therapy represents a crucial advancement in the treatment of urologic cancers, emphasizing not just the longevity of life, but the quality of life after diagnosis and treatment. In the realm of prostate, kidney, and bladder cancer, this approach can lead to effective outcomes while minimizing the impact on organ function and overall well-being.

Precision Transperineal Biopsy
This minimally invasive technique allows for accurate sampling of prostate tissue with reduced risk of complications. By targeting specific areas, precision transperineal biopsy enhances the diagnostic process and informs treatment decisions, contributing to more personalized care.

Focal Therapy for Prostate Cancer
Focal therapy targets only the cancerous portion of the prostate, preserving healthy tissue. This approach not only maintains urinary and sexual function but also helps mitigate the side effects commonly associated with more invasive treatments. Focal therapy options, such as high-intensity focused ultrasound (HIFU) or Irreversible electroporation (IRE/Nanoknife) provide effective cancer control while prioritizing the patient's quality of life.

Partial Nephrectomy for Kidney Cancer
In cases of kidney cancer, partial nephrectomy allows for the removal of the tumor while conserving as much healthy kidney tissue as possible. This organ-sparing approach is critical, particularly in patients with solitary kidneys or those at risk of chronic kidney disease. It ensures that patients retain greater renal function post-surgery, directly influencing their long-term health and lifestyle.

Partial Cystectomy for Bladder Cancer
For bladder cancer, partial cystectomy offers a means to remove cancerous portions of the bladder while preserving healthy tissue. This treatment choice not only improves the chances of maintaining normal bladder function but also supports the overall quality of life, reducing the likelihood of more drastic interventions that may impact urinary control.

In all these scenarios, it’s vital to recognize that successful cancer treatment is about more than just extending life; it’s about ensuring patients maintain their independence and quality of life in the process. An organ-sparing approach is an essential consideration in the management of urologic cancers, aligning treatment strategies with patients’ values and lifestyle goals.

The further I advance in my career, the more gratifying successful utilization of these approaches becomes.

James M Bienvenu MD - Advanced Urologic Cancer Treatments